ACSL4 promotes ferroptosis and M1 macrophage polarization to regulate the tumorigenesis of nasopharyngeal carcinoma

Background: Nasopharyngeal carcinoma (NPC) is a head and neck malignant tumor with a high incidence and recurrence rate. The crosstalk between ferroptosis and tumor-associated macrophages (TAMs) is thought to have major implications in interfering with cancers. We intended to explore the effect of acyl-CoA synthetase long -chain family member 4 (ACSL4) on the pathogenesis of NPC via ferroptosis and TAMs. Methods: Differential genes in NPC patients were analyzed using publicly available databases, and the ferroptosis-related gene ACSL4 was identified. Expression of ACSL4 in NPC cell lines and xenografted mice was examined. Colony formation, cell proliferation, migration, and invasion were assessed. The abundance of epithelial-mesenchymal transition (EMT) markers (E-cadherin, N-cadherin, and Vimentin) was confirmed. Lipid peroxi-dation levels and related markers were measured. Clophosome was administered to determine the role of TAMs in NPC mice. Results: Low levels of ACSL4 were observed in NPC patients and CNE-2 and 5-8F cells. Erastin (a ferroptosis inducer) and ACSL4 increased lipid peroxidation, decreased cell viability, colony formation, cell proliferation, migration and invasion, and inhibited EMT. Moreover, Erastin and ACSL4 promoted M2 to M1 macrophage polarization. The effects of erastin and ACSL4 were additive. Ferrostatin-1, an inhibitor of ferroptosis, exerted the opposite effect and reversed the beneficial effects of ACSL4 overexpression. In xenograft mice, ACSL4 and clo-phosome hindered the growth of NPC, and extra clophosome slightly enhanced the antitumor effect of ACSL4. Conclusion: Our findings indicated that ACSL4 inhibited the pathogenesis of NPC, at least through crosstalk between ferroptosis and macrophages, providing potential direction for NPC therapy.

Automated summary

This study explored the effect of acyl-CoA synthetase long-chain family member 4 (ACSL4) on the pathogenesis of nasopharyngeal carcinoma (NPC) through the crosstalk between ferroptosis and tumor-associated macrophages (TAMs). It was found that ACSL4 inhibited the development of NPC by activating ferroptosis and altering the phenotype of TAMs. These findings provide a new potential direction for NPC therapy.